secwatch.observer — SEC 8-K summary
======================================

Issuer:     STAAR SURGICAL CO (STAA)
CIK:        0000718937
Form:       8-K
Filed at:   2024-03-18T23:59:59+00:00
Accession:  0000950170-24-032512
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STAAR Surgical surpasses 3 million cumulative ICL sales globally
----------------------------------------------------------------

- More than 3 million Implantable Collamer Lenses (ICLs) sold worldwide; EVO ICL accounts for ~2.5 million of that total.
- CEO Tom Frinzi cites EVO ICL as next logical step in refractive innovation with clear patient outcome differentiators.
- Milestone reflects growing adoption for myopia, astigmatism, and presbyopia correction via minimally invasive procedure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/718937/000095017024032512/0000950170-24-032512-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/718937/000095017024032512/staa-20240318.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-032512

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer